
07 Jul 2021
PANMURE: Oxford Biomedica : Embracing the CDMO opportunity
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
PANMURE: Oxford Biomedica : Embracing the CDMO opportunity
Oxford BioMedica plc (OXB:LON) | 604 48.3 1.3% | Mkt Cap: 726.0m
- Published:
07 Jul 2021 -
Author:
Dr Mike Mitchell | Julie Simmonds -
Pages:
12 -